IT1158037B - Derivati piperazinici del benzoisotiazolo e del benzoisoossazolo aventi attivita' antipsicotica selettiva relativo procedimento di produzione e preparati farmaceutica che li contengono - Google Patents

Derivati piperazinici del benzoisotiazolo e del benzoisoossazolo aventi attivita' antipsicotica selettiva relativo procedimento di produzione e preparati farmaceutica che li contengono

Info

Publication number
IT1158037B
IT1158037B IT49709/82A IT4970982A IT1158037B IT 1158037 B IT1158037 B IT 1158037B IT 49709/82 A IT49709/82 A IT 49709/82A IT 4970982 A IT4970982 A IT 4970982A IT 1158037 B IT1158037 B IT 1158037B
Authority
IT
Italy
Prior art keywords
benzoisoossazole
piperazinic
benzoisothiazole
derivatives
production process
Prior art date
Application number
IT49709/82A
Other languages
English (en)
Other versions
IT8249709A0 (it
Inventor
Davis L Temple
Joseph P Yevich
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8249709A0 publication Critical patent/IT8249709A0/it
Application granted granted Critical
Publication of IT1158037B publication Critical patent/IT1158037B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IT49709/82A 1981-12-23 1982-12-21 Derivati piperazinici del benzoisotiazolo e del benzoisoossazolo aventi attivita' antipsicotica selettiva relativo procedimento di produzione e preparati farmaceutica che li contengono IT1158037B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/333,830 US4411901A (en) 1981-12-23 1981-12-23 Benzisothiazole and benzisoxazole piperazine derivatives

Publications (2)

Publication Number Publication Date
IT8249709A0 IT8249709A0 (it) 1982-12-21
IT1158037B true IT1158037B (it) 1987-02-18

Family

ID=23304433

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49709/82A IT1158037B (it) 1981-12-23 1982-12-21 Derivati piperazinici del benzoisotiazolo e del benzoisoossazolo aventi attivita' antipsicotica selettiva relativo procedimento di produzione e preparati farmaceutica che li contengono

Country Status (26)

Country Link
US (1) US4411901A (it)
JP (2) JPS58110576A (it)
KR (1) KR870001022B1 (it)
AU (1) AU550780B2 (it)
BE (1) BE895469A (it)
CA (1) CA1205806A (it)
CH (2) CH656617A5 (it)
CY (1) CY1376A (it)
DE (1) DE3247530A1 (it)
DK (2) DK160939C (it)
ES (4) ES8401970A1 (it)
FI (1) FI78697C (it)
FR (2) FR2521561B1 (it)
GB (1) GB2114119B (it)
GR (1) GR77108B (it)
HK (1) HK5088A (it)
HU (2) HU195806B (it)
IE (1) IE54789B1 (it)
IT (1) IT1158037B (it)
KE (1) KE3718A (it)
LU (1) LU84550A1 (it)
NL (1) NL8204910A (it)
PT (1) PT76017B (it)
SE (2) SE453502B (it)
SG (1) SG30087G (it)
ZA (1) ZA828544B (it)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4656280A (en) * 1984-03-07 1987-04-07 E. I. Du Pont De Nemours And Company Radioiodinated dopamine receptor ligand
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
US4656173A (en) * 1985-04-24 1987-04-07 Bristol-Myers Company Antipsychotic benzisothiazole S-oxide compound
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
MX174210B (es) * 1987-02-17 1994-04-28 Pfizer Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US4855430A (en) * 1987-11-12 1989-08-08 American Home Products Corporation Polycyclicamine with psychotropic activity
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
ATE81123T1 (de) * 1987-11-20 1992-10-15 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl>-4thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
WO1990002552A1 (en) * 1988-09-16 1990-03-22 Pfizer Inc. Antipsychotic 4-[4-(3-benzisothiazolyl)-1-piperazinyl]butyl bridged bicyclic imides
US4847252A (en) * 1988-10-25 1989-07-11 Bristol-Myers Company Method for alleviation of vascular headache
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
US5098904A (en) * 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
GB9226857D0 (en) * 1992-12-23 1993-02-17 Boyd Edward A Pharmaceutical compositions
US5599815A (en) * 1993-02-04 1997-02-04 Meiji Seika Kabushiki Kaisha Antipsychotic benzoisothiazolyl piperazine derivatives
HUT69376A (en) * 1993-05-04 1995-09-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing heterocyclic compounds
PL187404B1 (pl) 1995-02-28 2004-07-30 Lundbeck & Co As H Związki 4-aminotetrahydrobenzoizoksazolowe i-izotiazolowe oraz zawierające je kompozycje farmaceutyczne
WO1996039397A1 (en) * 1995-06-06 1996-12-12 Hoechst Marion Roussel, Inc. Benzisoxazole and indazole derivatives as antipsychotic agents
EP1757292A1 (en) 1997-09-05 2007-02-28 Pfizer Products Inc. Method of treating ocd and tic disorders
AU4062900A (en) * 1999-04-06 2000-10-23 Sepracor, Inc. Methods and compositions for the treatment of neuroleptic and related disorders using ziprasidone metabolites
US7030142B1 (en) 1999-04-06 2006-04-18 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites
EP1558608A1 (en) * 2002-10-28 2005-08-03 Warner-Lambert Company LLC Oxindole substituted piperazine derivatives
CA2505397A1 (en) * 2002-11-08 2004-05-21 Warner-Lambert Company Llc Phenylalkyl and pyridylalkyl piperazine derivatives
EP2578216A1 (en) 2006-11-22 2013-04-10 Seaside Therapeutics, Inc. Methods of treating fragile x syndrome
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
CN105669665A (zh) * 2016-03-15 2016-06-15 烟台贝森医药科技有限公司 哌罗匹隆的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595920B2 (de) * 1964-11-04 1978-08-10 Merck Patent Gmbh, 6100 Darmstadt 4-(co-Piperazinoalkyl)-pyrazole, ihre Salze und Verfahren zu ihrer Herstellung
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
DE1670907B2 (de) * 1967-08-16 1976-07-22 Bayer Ag, 5090 Leverkusen N-disubstituierte 3-amino-1,2benzisothiazole und verfahren in ihrer herstellung
US3528989A (en) * 1967-11-14 1970-09-15 Colgate Palmolive Co 3-aminoalkyl derivatives of 2,1-benzisothiazoline
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
AR207986A1 (es) * 1974-07-01 1976-11-22 Sumitomo Chemical Co Un procedimiento para producir compuestos del 3-(aminoalquil n-sustituido)-benz-2,1-isoxazol
US3940398A (en) * 1975-01-23 1976-02-24 E. R. Squibb & Sons, Inc. 2-[[4-(Azine or diazine or triazine)-1-piperazinyl]alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
DE2734866A1 (de) * 1977-08-03 1979-02-22 Basf Ag Neue 1,2-benzisothiazole und verfahren zu ihrer herstellung
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
AU521110B2 (en) * 1978-06-20 1982-03-18 Synthelabo Phenylpiperazine derivatives

Also Published As

Publication number Publication date
ES525471A0 (es) 1985-02-01
LU84550A1 (fr) 1983-09-08
HU195806B (en) 1988-07-28
JPS58110576A (ja) 1983-07-01
FI824379L (fi) 1983-06-24
FR2531431A1 (it) 1984-02-10
FI824379A0 (fi) 1982-12-20
GR77108B (it) 1984-09-06
SE8207350D0 (sv) 1982-12-22
SE8702389L (sv) 1987-06-09
DK566282A (da) 1983-06-24
DK307590D0 (da) 1990-12-28
CH659070A5 (de) 1986-12-31
FR2521561A1 (fr) 1983-08-19
SE453502B (sv) 1988-02-08
BE895469A (fr) 1983-06-23
ZA828544B (en) 1983-09-28
KR870001022B1 (ko) 1987-05-23
GB2114119B (en) 1985-11-27
ES8503349A1 (es) 1985-02-01
DE3247530A1 (de) 1983-06-30
ES518168A0 (es) 1984-01-16
KE3718A (en) 1987-04-16
US4411901A (en) 1983-10-25
SE462162B (sv) 1990-05-14
ES8401970A1 (es) 1984-01-16
ES525470A0 (es) 1985-02-01
IE54789B1 (en) 1990-02-14
SG30087G (en) 1987-07-17
GB2114119A (en) 1983-08-17
IE823053L (en) 1983-06-23
IT8249709A0 (it) 1982-12-21
PT76017B (en) 1985-12-20
ES8503683A1 (es) 1985-04-01
DK160939B (da) 1991-05-06
DK162601B (da) 1991-11-18
SE8702389D0 (sv) 1987-06-09
FI78697C (fi) 1989-09-11
HU190997B (en) 1986-12-28
DK307590A (da) 1990-12-28
ES524946A0 (es) 1985-04-01
PT76017A (en) 1983-01-01
JPH0517457A (ja) 1993-01-26
CA1205806A (en) 1986-06-10
DK162601C (da) 1992-05-11
SE8207350L (sv) 1983-08-10
AU550780B2 (en) 1986-04-10
NL8204910A (nl) 1983-07-18
HK5088A (en) 1988-01-29
FR2521561B1 (fr) 1986-10-10
KR840002832A (ko) 1984-07-21
DK160939C (da) 1991-10-21
CY1376A (en) 1987-08-07
FR2531431B1 (it) 1986-10-10
CH656617A5 (de) 1986-07-15
ES8502991A1 (es) 1985-02-01
FI78697B (fi) 1989-05-31
JPH0577669B2 (it) 1993-10-27
AU9087282A (en) 1983-06-23

Similar Documents

Publication Publication Date Title
IT1158037B (it) Derivati piperazinici del benzoisotiazolo e del benzoisoossazolo aventi attivita' antipsicotica selettiva relativo procedimento di produzione e preparati farmaceutica che li contengono
DE3261237D1 (en) Sulphur-containing 5-hydroxy-alkanoic acid derivatives, their use as pharmaceutical preparations and process for their production
KR870700602A (ko) 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도
HUT41009A (en) Process for production of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and its derivatives and medical preparatives containing thereof as active substance
HUT43604A (en) Process for production of derivatives of benzolsulphanil or sulphinil-amin-indolisine and pharmaceutic preparations containing those
IT8648157A0 (it) Derivati del tiazolo, loro preparazione e composizioni farmaceutiche che li contengono
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
FR2578540B1 (fr) Nouveaux derives de pyridylmethoxy- et -methylmercaptoanilines, utilses notamment comme antiasthmatiques, leur fabrication et medicaments les contenant
CS357991A3 (en) Benzimidazole derivatives, process of their preparation and pharmaceutical compositions comprising said derivatives
ZA794371B (en) Acid addition salts of 16 beta -monoquaternary ammonium derivatives of 2 beta,16 beta-bis-piperidino-androstanes and pharmaceutical preparations containing same
IT8847794A0 (it) Derivati dell'acido furanuronico, loro preparazione e loro impiego come medicamenti
IT8519418A1 (it) Derivati del 3-metil-imidazo [ 4,5-c] pirazolo con attività terapeutica e procedimento per la loro preparazione
GB2095668B (en) Acylquinolinone derivatives process for their manufacture pharmaceutical preparations containing them and their use
HUT40106A (en) Process for production of medically active derivatives of dihydropiridin and medical preparatives containing thereof
FR2344531A1 (fr) Nouveaux derives de l'acide sulfonamidobenzoique, leur procede de preparation et medicaments les contenant
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
IT8748709A0 (it) Derivati dell'acido furanuronico, loro preparazione e loro impiego come medicamenti
BE881278A (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
IT1194793B (it) Derivati tiazolidinici ad attivita' farmacologica,procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati
PT82364B (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
IT8621112A0 (it) Derivati dell'acido tiazolidin-4-carbossilico adattivita' farmaceutica.
IT8348309A0 (it) Derivati del 2(hi)-piridinone, loro preparazione e loro impiego come medicamenti
IT1123503B (it) Derivati di acidi aziridin-2-carbossilici n-sostituiti con attivita'immunostimolante,processi per la loro preparazione e farmaci contenenti tali sostanze
FR2556725B1 (fr) Derives de 4,5,6,7-tetrahydrothiazolo (5,4-c) pyridine, procedes pour les preparer et medicament les contenant
IT8449056A0 (it) Derivati dell'1,2-ditiolano,loro preparazione e loro impiego come medicamenti

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227